Accurate interpretation of the organic acid chromatographs obtained from the gas chromatography/mass spectrometry requires a significant amount of practice. Pattern recognition is an important factor and a skill that is gained through time and effort.
A Quick Guide to Metabolic Disease Testing Interpretation, Second Edition, provides these example chromatographs demonstrating specific disease-related metabolites for the inborn error of metabolism diagnosed via this method. One or more representative chromatographs from each of the common disorders is presented, with the important compounds noted on the chromatographs. This is a must-have for laboratory and medical professionals who interpret testing for the diagnosis and monitoring of IEM.
- Includes pathway diagrams and representative compound scans of important diagnostic compounds
- Provides illustrative chromatographs from selected disorders to aid in diagnosing common inborn errors of metabolism
- Highlights brief descriptions of the etiology and clinical presentation of each presented disorder
Recenzijas
"If this is your area of laboratory or clinical practice - two words: get it." --Doody
Section 1 Introduction1. Introduction
Section 2 Organic acidurias2. Disorder: Glutaric acidemia type
13. Disorder:
Glutaric acidemia type
24. Disorder: 2-Hydroxyglutaric aciduria5. Disorder:
Isovaleric aciduria6. Disorder: 2-Methylbutyrylglycinuria7. Disorder:
3-Methylcrotonyl-CoA-carboxylase deficiency8. Disorder: 3-Methyglutaconic
aciduria9. Disorder: Methylmalonic aciduria10. Disorder: Propionic
acidemia11. Disorder: Succinic semialdehyde dehydrogenase deficiency
Section 3 Urea cycle defects12. Disorder: Arginase deficiency13. Disorder:
Argininosuccinic acidemia14. Disorder: Carbamyl phosphate synthetase 1
deficiency and N-acetylglutamate synthase deficiency15. Disorder:
Citrullinemia and citrin deficiency16. Disorder:
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome17. Disorder:
Ornithine transcarbamylase deficiency
Section 4 Disorders of amino acid metabolism18. Disorder: -Ketothiolase
deficiency19. Disorder: Lysinuric protein intolerance20. Disorder: Maple
syrup urine disease21. Disorder: Glycine encephalopathy22. Disorder:
Phenylketonuria23. Disorder: Tyrosinemia type
124. Disorder: Tyrosinemia
types 2 and 3
Section 5 Fatty acid oxidation defects25. Disorder: Carnitine-acylcarnitine
translocase deficiency26. Disorder: Carnitine palmitoyltransferase 1
deficiency27. Disorder: Carnitine palmitoyltransferase 2 deficiency28.
Disorder: Carnitine transporter deficiency29. Disorder: Long chain
3-hydroxyacyl-CoA dehydrogenase deficiency30. Disorder: Medium-chain acyl-CoA
dehydrogenase deficiency31. Disorder: Short chain 3-hydroxyacyl-CoA
dehydrogenase deficiency32. Disorder: Very long chain acyl CoA dehydrogenase
deficiency
Section 6 Other metabolic disorders33. Disorder: Biotin: Biotinidase
deficiency and holocarboxylase synthetase deficiency34. Disorder: Canavan
Disease35. Disorder: Dihydropyrimidine dehydrogenase deficiency36. Disorder:
Glutathione synthetase deficiency37. Disorder: Pyruvate dehydrogenase
deficiency
Dr. Jones is the Clinical Director of the Chemistry and Metabolic Disease Lab at Childrens Medical Center of Dallas and a Professor of Pathology at UT Southwestern Medical Center. Her PhD is in Molecular Biology with a minor in Biochemistry. Her duties include instructing pathology residents and various fellows in aspects of clinical chemistry and metabolic disease testing, and acting as a clinical consultant at the Dallas County hospital (Parkland) and the university hospital system. Her research interests lie in the field of inborn errors of metabolism, especially disorders of fatty acid metabolism. Dr. Jones has been an active member of the American Association for Clinical Chemistry (AACC) since 1986, serving on numerous committees for that association. She is currently the AACC President-elect and will be AACC President in 2016. She is the Past-President of the National Academy of Clinical Biochemists (NACB) and American Association for Clinical Chemistry (AACC). Dr. Patel is an Assistant Professor and Associate Director of Clinical Chemistry, Children's Health at UT Southwestern. She received her PhD in Molecular Cell Biology from Washington University in St. Louis, MO. Dr. Rakheja did his medical schooling at All India Institute of Medical Sciences in New Delhi. He completed pathology residencies at Maulana Azad Medical College (Delhi University) and UT Southwestern Medical Center. He trained in gastrointestinal pathology and neuropathology as a senior resident (fellow equivalent) at GB Pant Hospital (Delhi University) and completed a pediatric pathology fellowship at UT Southwestern/Childrens Medical Center. Dr. Rakheja studies the genetics and metabolism of childhood cancer. He has specific interests in tumor tissue banking, establishing primary pediatric cancer cell lines, and developing laboratory assays for diagnostic, prognostic, and therapeutic targets in pediatric cancers.
